GRVE 8-K
Groove Botanicals Inc. (GRVE)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
CURRENT REPORT
Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934
Date of Report:
(Exact name of registrant as specified in its charter)
Commission
File Number:
| (State of incorporation) | (IRS Employer Identification No.) |
| (Address of Principal Executive Offices) | (Zip Code) |
Registrant’s telephone number, including
area code:
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | Trading Symbol(s) | Name of each exchange on which | ||
Indicate by check mark whether the registrant is an emerging growth company as
defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934
(§ 240.12b-2 of this chapter). Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected
not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section
13(a) of the Exchange Act.
TABLE OF CONTENTS
Item 4.01 - Changes in Company's Certifying Accountant
Item 9.01 - Financial Statements and Exhibits
SIGNATURES
EXHIBIT INDEX
Item 4.01 Changes in Company’s Certifying Accountant
The Board of Directors of Groove Botanicals Inc. (the “Company”) undertook a decision to reconsider its engagement with TAAD LLP (“TAAD”) as the Company’s independent registered public accounting firm for the fiscal year ending March 31, 2023.
After careful deliberation, the Board of Directors has determined to engage BF Borgers CPA PC (“Borgers”) as the Company’s independent registered public accounting firm, effective immediately. In alignment with this decision, the Audit Committee officially dismissed TAAD from its role as the Company’s certifying accountant on March 9, 2023.
For clarity, the audit reports of TAAD on the Company’s consolidated financial statements for the fiscal years ended March 31, 2020, 2021 and 2022 did not contain any adverse opinions, disclaimers of opinion, and were not qualified or modified regarding uncertainty, audit scope, or accounting principles. Throughout the fiscal years ending March 31, 2020-2022, and up to the date of this report, the Company and TAAD maintained a professional relationship with no disagreements on matters of accounting principles, financial statement disclosure, or audit procedures. There were no instances or circumstances that would have necessitated TAAD to reference any disagreements in their audit reports for those years. Additionally, no "reportable events" as defined in Item 304(a)(1)(v) of Regulation S-K occurred.
In the spirit of full transparency, the Company has furnished TAAD with a copy of the disclosures contained within this Current Report on Form 8-K, seeking TAAD's confirmation on the accuracy and alignment of these statements. A copy of the Company’s communication with TAAD, dated August 28, 2023, is appended as Exhibit 16.1. To date, TAAD has not responded to the issue of confirmation.
To further clarify, during the fiscal years ending March 31, 2020-2022, and and throughout 2023, as well as the subsequent interim period leading up to this report, neither the Company nor any representatives acting on its behalf initiated consultations with Borgers concerning any of the matters outlined in Item 304(a)(2)(i) or 304(a)(2)(ii) of Regulation S-K.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits
| Exhibit No. | Description |
| Exhibit 16.1 | Letter of Kent Rodriguez to TAAD LLP Dated: August 23, 2023 |
| Exhibit 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Groove Botanicals Inc.
(Registrant)
| Date: August 28, 2023 | /s/ Kent Rodriguez (Signature) | |
| Name: | Kent Rodriguez | |
| Title: | Chief Executive Officer | |
Exhibit 16.1
GROOVE BOTANICALS INC.
310 FOURTH AVENUE SOUTH, SUITE 7000
MINNEAPOLIS, MN 5541
August 23, 2023
TAAD LLP
20955 Pathfinder Road, Suite 370,
Diamond Bar, CA 91765, USA
Subject: Request for Item 304 Disclosure Letter and Form 8-K Acknowledgment
Dear TAAD, LLP Team,
I trust this message finds you well.
As you are already aware, Groove Botanicals found itself in a position where waiting for the completion of the audit was no longer feasible. The prolonged delays seriously jeopardized the company’s value and progress. In light of these challenges, we engaged CF Borges, and they expediently finalized the audit.
In compliance with the SEC’s requirements for our Form 10 filing, we now request an Item 304 disclosure letter from TAAD, LLP. Attached, you will find the draft letter, which requires your approval and signature. Alongside this, we have prepared a Form 8-K, also attached for your reference.
I’d like to point out that the SEC has explicitly instructed us to give TAAD, LLP the opportunity to affirm the statements in the letter. However, they also made it clear that should there be any hesitancy or lack of cooperation on your part, Groove Botanicals can proceed with filing the 8-K, noting therein that mutual cooperation was unattainable.
Your prompt attention to this matter will be greatly appreciated. Kindly advise us at your earliest convenience, so we can take the necessary steps to move the company forward.
Warm regards,
/s/ Kent Rodriguez CEO
Chief Executive Officer
Groove Botanicals Inc.
(612-315-5068)
310 Fourth Avenue South, Suite 700
Minneapolis, MN 55415